Рет қаралды 2,847
This webinar focuses on FDA’s Project Optimus and its potential impacts on oncology drug development.
Certara accelerates medicines to patients using proprietary biosimulation software and technology to transform traditional drug discovery and development. Its clients include 1,600 global biopharmaceutical companies, leading academic institutions, and key regulatory agencies across 60 countries.
Please visit us at www.certara.com/